Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-07

Clinical Trial Update: Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial studying safety and efficacy of topically applied DS107 cream in mild to moderate atopic dermatitis; study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DS107 cream (DS107)

Snippet

Sponsor: DS Biopharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-07